Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Tositumomab

EU orphan designation number: EU/3/03/137
Active ingredient: Tositumomab
Indication: Treatment of follicular lymphoma
Sponsor: GlaxoSmithKline Research & Development Limited
1-3 Iron Bridge Road, Stockley Park West, Uxbridge, Middlesex UB11 1BT, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/02/2003 Orphan Designation EMEA/OD/079/02 (2003)590 of 14/02/2003
12/08/2005 Transfer of orphan designation EMEA/OD/079/02/T/01 (2005)3178 of 10/08/2005
30/05/2011 Change of address of sponsor EMEA/OD/079/02
18/03/2015 Removal of orphan designation from Community Register